Adtalem Global Education (NYSE:CVSA) CEO Stephen Beard Sells 2,529 Shares of Stock

Adtalem Global Education Inc. (NYSE:CVSA) CEO Stephen Beard sold 2,529 shares of Adtalem Global Education stock in a transaction that occurred on Thursday, June 11th. The stock was sold at an average price of $130.78, for a total transaction of $330,742.62. Following the transaction, the chief executive officer directly owned 424,033 shares in the company, valued at $55,455,035.74. The trade was a 0.59% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Adtalem Global Education Price Performance

Adtalem Global Education stock opened at $128.23 on Friday. The business’s 50 day moving average price is $120.70. Adtalem Global Education Inc. has a fifty-two week low of $86.97 and a fifty-two week high of $156.26. The company has a market cap of $4.36 billion, a price-to-earnings ratio of 19.97, a price-to-earnings-growth ratio of 1.09 and a beta of 0.62. The company has a quick ratio of 0.70, a current ratio of 0.70 and a debt-to-equity ratio of 0.36.

Adtalem Global Education (NYSE:CVSA) last released its quarterly earnings data on Thursday, May 7th. The company reported $1.98 earnings per share for the quarter, topping the consensus estimate of $1.73 by $0.25. Adtalem Global Education had a net margin of 12.26% and a return on equity of 20.19%. The business had revenue of $487.03 million for the quarter. During the same period in the previous year, the business earned $1.92 EPS. The firm’s revenue was up 4.5% compared to the same quarter last year. Adtalem Global Education has set its FY 2026 guidance at 7.950-8.150 EPS. As a group, analysts predict that Adtalem Global Education Inc. will post 8.04 EPS for the current fiscal year.

Analyst Ratings Changes

Several research analysts recently weighed in on CVSA shares. Wall Street Zen raised shares of Adtalem Global Education from a “hold” rating to a “buy” rating in a research note on Saturday. Zacks Research lowered shares of Adtalem Global Education from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, March 25th. Barrington Research reissued an “outperform” rating and set a $170.00 price objective on shares of Adtalem Global Education in a research note on Monday, June 8th. Truist Financial lifted their price objective on shares of Adtalem Global Education from $130.00 to $140.00 and gave the stock a “buy” rating in a research note on Monday, May 11th. Finally, Weiss Ratings reissued a “hold (c+)” rating on shares of Adtalem Global Education in a research note on Friday, May 22nd. Two research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $155.00.

About Adtalem Global Education

Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.